A prospective, cohort study of safety of four COVID-19 vaccines (Pfizer's Comirnaty(®), Moderna's Spikevax(®), AstraZeneca's Vaxzevria(®) and the Janssen vaccine) in Netherlands
Latest Information Update: 31 Mar 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 31 Mar 2022 New trial record
- 12 Mar 2022 Results published in the Drug Safety